Opendata, web and dolomites

MARSI SIGNED

Disruptive technologies for effectively rehabilitating chronic ambulatory disability

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MARSI project word cloud

Explore the words cloud of the MARSI project. It provides you a very rough idea of what is the project "MARSI" about.

industrialization    neuromuscular    min    house    enlarge    paraplegia    complications    musculoskeletal    active    muscle    critical    restore    81    share    acquiring    palsy    jobs    patients    14    renting    correspond    life    injury    losing    limited    strength    36m    disorder    bifida    remaining    physical    ambulatory    roughly    alliance    disorders    nervous    effortlessly    covers    autonomy    15    programs    medicines    impedes    treatments    spina    frame    company    2023    quality    million    disabled    difficulty    ares    lower    expectancy    joining    showing    functional    cerebral    mobility    progressive    marsi    expensive    certification    week    turnover    disability    cord    time    avoiding    market    stroke    powered    psychosocial    minimal    neurological    device    minimize    elders    walk    daily    sessions    barrier    muscles    bionics    function    everyday    speed    overcome    therapeutic    synchronized    dementia    models    walking    worlwide    quadriplegia    spinal    sme    physically    sum    people    diseases    lifestyle    commercialized    industrial    safely    orthoses    health    joints    rehabilitation    weakness    escribano    motor    portfolio   

Project "MARSI" data sheet

The following table provides information about the project.

Coordinator
MARSI BIONICS SL 

Organization address
address: CALLE RUE DEL PERCEBE 30
city: RIVAS VACIAMADRID
postcode: 28521
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.marsibionics.com/
 Total cost 2˙499˙150 €
 EC max contribution 1˙640˙730 € (66%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-03-01   to  2020-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MARSI BIONICS SL ES (RIVAS VACIAMADRID) coordinator 1˙640˙730.00

Map

 Project objective

Worlwide, about 60 million people have some kind of difficulty in walking, which is related to some neurological disorder (stroke, dementia, neuromuscular diseases, etc). Roughly 40 million of affected correspond to elders and the % is higher in Europe. The remaining is the sum of physically disabled by cerebral palsy (14 million), neuromuscular diseases (4 million), spinal cord injury (paraplegia and quadriplegia, 3 million) and spina bifida (3 million). Neurological disorders affect the lower motor of the nervous system and share the progressive muscle weakness, which lead to several walk disability, loss of autonomy and psychosocial consequences. Most therapeutic treatments are limited to medicines and musculoskeletal rehabilitation programs, which are very expensive and limited to 15-30 min/week rehabilitation sessions. Active lifestyle is the most effective measure to restore the physical conditions. But the loss of muscle strength impedes the ambulatory function. The need is for a device allowing them walking effortlessly and safely in the everyday life activities. Based on our ARES technology, -the minimal functional unit providing synchronized joints-muscles mobility- Marsi Bionics has developed powered orthoses for in-house rehabilitation of patients affected by muscle weakness disorders, showing a product portfolio that covers the needs of a wide range of Neurological Disorders. Marsi products will be commercialized under renting models allowing patients acquiring it for daily use. This technology will improve these patients life quality and enlarge life expectancy by avoiding critical health complications of losing walking ability. Marsi is strengthened by joining with a leading company in the current industrial market, ESCRIBANO. This alliance in the frame of SME Phase 2 will speed up industrialization, overcome the certification barrier and minimize the time to market. As a result, we expect to reach above 36M€ turnover in 2023 and 81 generated jobs.

 Deliverables

List of deliverables.
Dissemination and Communication continuous monitoring (actions, results, congresses, materials and KPI. Documents, reports 2020-03-04 09:47:52

Take a look to the deliverables list in detail:  detailed list of MARSI deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MARSI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MARSI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

PRIDIKTIV (2017)

Pridiktiv - Exploring European expansion through 4 pilot studies

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More